Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level
Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level
复制标题
DOI：
10.1016/j.chom.2020.05.013
复制
发表时间：
2020-08-12
影响因子：
30.3
通讯作者：
Xavier, Ramnik J.
中科院分区：
文献类型：
--
作者：
Kenny, Douglas J.;Plichta, Damian R.;Xavier, Ramnik J.
人类微生物组编码了广泛的代谢能力，但我们对肠道微生物与人类代谢联系的机制的理解仍然有限。在这里，我们将重点放在肠道微生物群将胆固醇转化为不易吸收的甾醇coprostanol上，以建立一个识别功能酶和微生物的框架。通过将现有队列的配对宏基因组学和代谢组学数据与生化知识和实验相结合，我们预测并验证了一组有助于形成coprostanol的微生物胆固醇脱氢酶。这些酶是由未培养微生物中的ismA基因编码的，这些微生物在地理上不同的人类群体中普遍存在。携带促前列腺醇形成微生物的个体，其粪便胆固醇水平和血清总胆固醇水平显著降低，其效果与脂质稳态基因的变化相当。因此，这些微生物的胆固醇代谢可能在降低肠道和血清胆固醇浓度方面发挥重要作用，直接影响人类健康。
The human microbiome encodes extensive metabolic capabilities, but our understanding of the mechanisms linking gut microbes to human metabolism remains limited. Here, we focus on the conversion of cholesterol to the poorly absorbed sterol coprostanol by the gut microbiota to develop a framework for the identification of functional enzymes and microbes. By integrating paired metagenomics and metabolomics data from existing cohorts with biochemical knowledge and experimentation, we predict and validate a group of microbial cholesterol dehydrogenases that contribute to coprostanol formation. These enzymes are encoded by ismA genes in a Glade of uncultured microorganisms, which are prevalent in geographically diverse human cohorts. Individuals harboring coprostanol-forming microbes have significantly lower fecal cholesterol levels and lower serum total cholesterol with effects comparable to those attributed to variations in lipid homeostasis genes. Thus, cholesterol metabolism by these microbes may play important roles in reducing intestinal and serum cholesterol concentrations, directly impacting human health.